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ABSTRACT
Objective To determine the effectiveness of early
physiotherapy in reducing the risk of secondary
lymphoedema after surgery for breast cancer.
Design Randomised, single blinded, clinical trial.
Setting University hospital in Alcalá de Henares, Madrid,
Spain.
Participants120womenwhohadbreast surgery involving
dissection of axillary lymphnodes betweenMay2005and
June 2007.
Intervention The early physiotherapy group was treated
by a physiotherapist with a physiotherapy programme
including manual lymph drainage, massage of scar
tissue, and progressive active and action assisted
shoulder exercises. This group also received an
educational strategy. The control group received the
educational strategy only.
Main outcome measure Incidence of clinically significant
secondary lymphoedema (>2 cm increase in arm
circumference measured at two adjacent points
compared with the non-affected arm).
Results 116 women completed the one year follow-up. Of
these, 18 developed secondary lymphoedema (16%): 14
in the control group (25%) and four in the intervention
group (7%). The difference was significant (P=0.01); risk
ratio 0.28 (95% confidence interval 0.10 to 0.79). A
survival analysis showed a significant difference, with
secondary lymphoedema being diagnosed four times
earlier in the control group than in the intervention group
(intervention/control, hazard ratio 0.26, 95% confidence
interval 0.09 to 0.79).
Conclusion Early physiotherapy could be an effective
intervention in the prevention of secondary lymphoedema
in women for at least one year after surgery for breast
cancer involving dissection of axillary lymph nodes.
Trial registration Current controlled trials
ISRCTN95870846.
INTRODUCTION
Acquired interruption or damage to the axillary lym-
phatic system after surgery or radiotherapy for breast
cancer can lead to regional or generalised accumula-
tion of lymph fluid in the interstitial space, known as
secondary lymphoedema.1 This condition is the most
important chronic complication after dissection of the
axillary lymphnodes2-5 and has a tendency to progress.
Secondary lymphoedema can cause disfigurement,
physical discomfort, and functional impairment. Anxi-
ety, depression, and emotional distress are more
common in patients with than without secondary
lymphoedema. This can affect social relationships,
undermining body image and self esteem.6-8 The con-
dition may also precipitate cellulitis, erysipelas, lym-
phangitis, and occasionally lymphangiosarcoma.9-11
Reported incidence rates for secondary lympho-
edema vary depending on the method used for
measurement.12 Inconsistent definitions and the lack
of a standard classification system have resulted in
diverse incidence rates for secondary lymphoedema,
ranging from 5% to 56% within two years after
surgery.7 13-16 After axillary lymph node dissection the
incidence of secondary lymphoedema is about 23-38%
if the criterion used to identify it is a greater than 2 cm
increase in upper arm circumference measured at two
adjacent points compared with the circumferences in
the other arm.17 Most women (71%) develop second-
ary lymphoedema within 12 months after surgery for
breast cancer.18 19
The factors that might influence the development of
secondary lymphoedema after surgery are the number
of lymph nodes removed, radiotherapy to the axilla,
postoperative wound infection, postsurgical drainage
time, lack of mobility, and obesity.18 20-24
Currently, women with breast cancer have a 77%
probability of surviving at least 10 years.25 26 Conse-
quently the effective prevention and management of
complications that can impair function and affect qual-
ity of life after treatment are important.15
Efforts have beenmade to reduce the risk of second-
ary lymphoedema by preoperative and postoperative
counselling and education2728 and by early
detection.27 29 A randomised clinical trial on the
1Physiotherapy Department,
School of Physiotherapy, Alcalá de
Henares University, E-28871 Alcalá
de Henares, Madrid, Spain
2Príncipe de Asturias University
Hospital, Alcalá de Henares,
Madrid
3Medical Statistics Unit,
Department of Epidemiology and
Population Health, London School
of Hygiene and Tropical Medicine,
London
4Physiotherapy Department,
Provincial Hospital, Toledo, Spain
Correspondence to: M Torres
Lacomba maria.torres@uah.es
Cite this as: BMJ 2010;340:b5396
doi:10.1136/bmj.b5396
BMJ | ONLINE FIRST | bmj.com page 1 of 8
prevention of secondary lymphoedema through exer-
cises and an educational strategy, however, lacked suf-
ficient evidence.30 We determined the effectiveness of
an early physiotherapy programme in reducing the
risk of secondary lymphoedema in women after sur-
gery for breast cancer involving dissection of axillary
lymph nodes.
METHODS
We carried out a randomised, single blinded, clinical
trial of women after unilateral breast cancer surgery
with axillary lymph node dissection at the Príncipe de
Asturias Hospital in Madrid between May 2005 and
June 2007. We excluded women without axillary
lymph node dissection or with bilateral breast cancer,
systemic disease, locoregional recurrence, or any con-
traindication to physiotherapy.
Eligible women gave written informed consent to
participate in the study after breast cancer had been
confirmed by biopsy. Each participant was assessed
preoperatively and between days 3 and 5 after hospital
discharge. Equal numbers of women were then ran-
domly allocated by computer using EPIDAT version
3.1 (Xunta de Galicia, Spain)31 to either early physio-
therapy and an educational strategy (early physio-
therapy group) or the educational strategy only
(control group). Both programmes lasted three
weeks, with three visits each week. The main outcome
was the incidence of secondary lymphoedema.
Follow-up
Initially we scheduled four follow-up visits: four weeks
after surgery (shortly after the completion of the inter-
vention) and three, six, and 12 months after surgery.
These dates were, however, flexible, depending on
the participant’s availability. At all visits lympho-
edema was assessed using the same protocol.
If patients experienced pain, discomfort, or any
other symptoms, they could contact the physio-
therapist and a visit would be arranged. If secondary
lymphoedemawas diagnosed then complex deconges-
tive physiotherapy was carried out,32-34 which would
effectively interrupt follow-up.
Interventions
Each group had one physiotherapist, who carried out
all interventions. Before the study it was agreed that
both groups would receive the same educational inter-
vention. The physiotherapists had more than five
years’ experience in the treatment of vascular diseases
using lymphatic drainage. They were the only study
members aware of group allocation.
Early physiotherapy group—The intervention included
the manual lymph drainage technique used for the
treatment of postoperative oedema (thorax, breast,
axilla, and upper arm of affected side), using a modifi-
cation of the strokes described by Leduc (only resorp-
tion strokes were used)32 34; progressive massage of the
scar (progressing from Jacquet and Leroy pincer to
Wetterwald pincer)32 35; stretching exercises for levator
scapulae, upper trapezius, pectoralismajor, andmedial
and lateral rotators muscles of the shoulder36; and pro-
gressive active and action assisted shoulder exercises,
started in conjunction with functional activities and
proprioceptive neuromuscular facilitation exercises
without resistance (rhythmic initiation progressing
from passive to active-assistive to active movement in
two diagonal symmetrical bilateral patterns and asym-
metrical reciprocal patterns:D1 into flexion fromhitch
hike to swat fly, and into extension from swat fly to
hitch hike, and D2 into flexion from hand in opposite
pocket to carry tray, and into extension from carry tray
to hand in opposite pocket).37 If axillaryweb syndrome
was diagnosed the physiotherapy protocol extended
the manual lymph drainage technique to axilla and to
proximal ipsilateral arm and included specific thumb
manual lymph drainage on the characteristics taut
cords, to make them gradually more flexible. The
early physiotherapy group also did shoulder exercises
and stretching at home once daily during the three
week intervention period.
Educational strategy (both groups)—The educational
strategy consisted of instruction with printed materials
about the lymphatic system, concepts of normal load
versus overload, the source of secondary lympho-
edema, the identification of possible precipitating fac-
tors, and the four categories of interventions to prevent
secondary lymphoedema (avoidance of trauma or
injury, prevention of infection, avoidance of arm con-
striction, and use and exercise of the arm),27 28 38 39
together with individual strategies for implementing
these measures.
Assessments
A different physiotherapist did the two initial and four
follow-up assessments of all participants and remained
blinded to group allocation. Participants were
instructed not to reveal their allocation.
Lymphoedema—Direct measurement of the presence
and severity of lymphoedema is difficult and different
diagnostic criteria have been described, including
comparison between preoperative and postoperative
measurementswithin the affected armand comparison
of measurements between the affected and unaffected
arms.16 29 40-43 For ourmain analysis we used the criteria
stated in the trial protocol—that is, a 2 cm or greater
increase in the circumference of any two adjacent
points compared with measurements in the other
arm.19 41 44-46 We also carried out the analysis using
other criteria (data not shown).
Arm measurements—Whatever the criteria used for
diagnosing lymphoedema they are all based on
changes in size or volume of the arms. Arm circumfer-
encesweremeasured at each visit and always following
the same procedure, using a standard 1 cm wide,
retractable, fibreglass tailor’s tape measure (Babel,
Spain). With the patient in an upright sitting position
with both arms on a table, shoulders in neutral rotation
and flexion of 45°, and forearms at maximum supina-
tion, we measured the circumference at 5 cm intervals
along both arms, using the elbow fold as the reference
starting point. This has been reported as a valid and
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reliable method for accurately quantifying and diag-
nosing secondary lymphoedema.47-49
Other variables—During the preoperative assessment
we collected personal data on the participants, includ-
ing age, ethnicity, marital status, bodymass index, job,
educational level, socioeconomic status, information
on breast cancer, andmedical history. In postoperative
assessments, data were collected on the type of surgery
done, the number of lymph nodes removed, the use of
adjuvant treatment, and the development of seroma
and infection. Participants were also asked an open
question about whether they had any pain. If they
did, a physical examination was carried out to find
the source, including axillaryweb syndrome.Thediag-
nostic criteria for axillaryweb syndromewerepain and
restriction of range of motion in the shoulders, with
associated visible or palpable taut cords of tissue in
the axilla in maximal shoulder abduction.50-54 Other
secondary outcomes were measured according to the
protocol but are not reported here.
Statistical analysis
The clinical criterion we chose to determine lympho-
edema (binary variable) was based on changes in cir-
cumference along the arm (continuous variable). The
raw data are therefore measures of circumference. To
obtain the binary outcome several intermediate vari-
ables need to be computed from these measurements
(see web extra on bmj.com). The important variable
here would be themaximumdifference in arm circum-
ference between any two adjacent points. A patient
would have a diagnosis of secondary lymphoedema if
the maximum difference between any two adjacent
points was 2 cm or greater. Lymphoedema can also
be determined from the increase in volume ratio of
both arms (volume of affected arm divided by volume
of unaffected arm). 29 30 42 44 55 56 The volume ratio is
computed in the variable “change in volume ratio”
(presented as percentages). Although we chose not to
use this as part of our criteria for clinical diagnosis we
include a continuous analysis on this variable. This
variable can be easily interpreted as an increase or
decrease of the proportional difference of the volumes
of both arms (affected minus unaffected; see web extra
on bmj.com). Total armvolumewas calculated by add-
ing up all the partial volumes between every two adja-
cent measurements. Each of these partial volumes was
calculated by an approximation to a truncated cone
with the formula:
V=D(C12+C22+C1C2)/12 π
where C1 andC2 are the circumferences and the two
adjacent locations and D is the distance between C1
and C2. We have not included hand volume as this is
difficult to model with a truncated cone. Truncated
cone calculations of limb segment volumes using the
circumference of segments have been reported to be
reliable.16
Power calculations and sample size
Although the sample size was limited by patients’
availability we did some power calculations. With
this sample size and after 3% of dropouts, we would
have a power of 70% to detect a difference of 20% in
the incidence of secondary lymphoedema between the
groups. This assumes an incidence of 30% in the
control group (according to findings in earlier
studies16 17 19 44) and setting a type I error of 0.05.
Statistical analyses were done using Stata version
10.0.57 For the primary analysis we compared the
groups in threeways. Firstly,weused a binary outcome
analysis to compare the incidence of lymphoedema,
determined according to the chosen criteria. Secondly,
we used a continuous outcome analysis to compare the
variables “maximum difference in arm circumference
between two adjacent locations” and “change in
volume ratio.” Thirdly, as we had recorded the timing
of diagnosis of lymphoedemawe carried out a survival
Allocated to control group (n=60)
Control group intervention (n=57)
Did not receive allocated intervention (n=3);
  excluded
Allocated to early physiotherapy group (n=60)
Received early physiotherapy (n=59)
Did not receive allocated intervention (n=1);
  excluded
Assessed for eligibility (n=249)
Randomised (n=120)
Analysed (n=57)Analysed (n=59)
Excluded (n=129):
  Not meeting inclusion criteria (n=89)
  Refused to participate (n=22)
  Other reasons (n=18)
Fig 1 | Progress of participants through study
Table 1 | Comparison between randomised groups at baseline. Values are numbers
(percentages) unless stated otherwise
Variables
Sample
(n=120)
Early physiotherapy
group (n=60)
Control group
(n=60)
Mean (SD) age (years) 52.9 (11.6) 52.9 (10.7) 52.9 (12.5)
Mean (SD) body mass index 27.0 (5.1) 27.9 (5.6) 26.2 (4.5)
Mean (SD) volume ratio at baseline* 1.002 (0.04) 1.004 (0.05) 0.999 (0.03)
Mean (SD) maximum circumference† 0.45 (0.62) 0.54 (0.71) 0.37 (0.51)
In employment 48 (40) 23 (38) 25 (42)
Surgical procedure:
Quadrantectomy 50 (42) 24 (40) 26 (43)
Modified mastectomy 43 (36) 23 (38) 20 (34)
Lumpectomy 27 (22) 13 (22) 14 (23)
Mean (SD)Noofdissected lymphnodes 13.6 (5.2) 13.6 (5.1) 13.6 (5.4)
Mean (SD) No of days of drainage 4.3 (2.1) 4.1 (1.6) 4.5 (2.5)
Seroma 33 (28) 16 (27) 17 (28)
Wound infection 11 (9) 6 (10) 5 (8)
Axillary web syndrome after surgery 55 (46) 26 (43) 29 (48)
Postoperative therapy‡: (n=116) (n=59) (n=57)
Radiotherapy 93 (80) 44 (75) 49 (86)
Chemotherapy 95 (82) 50 (85) 45 (79)
Hormonal therapy 72 (62) 39 (66) 33 (58)
*Volume of affected arm to that of unaffected arm.
†Maximum difference measured between two adjacent points.
‡Excludes four patients lost to follow-up: three in early physiotherapy group and one in control group.
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analysis for the binary outcome. We compared the
incidence of lymphoedema using Fisher’s exact test.
Logistic regression was used when we needed to adjust
for other variables. For the continuous outcomes suffi-
cient data ensured the asymptotic properties of Stu-
dent’s t tests to compare means. A Cox proportional
hazard model was used to compare the survival rate
between the groups.
RESULTS
Of 120 women recruited, 60 were assigned to early
physiotherapy and an educational strategy and 60 to
the educational strategy only (fig 1). All variables
were similarly distributed between the groups at ran-
domisation (preoperative visit; table 1). The volume
ratioswere around 1 in both groups. Thiswas expected
as no lymphoedema was present at the preoperative
assessment. Overall, 116 women completed the fol-
low-up assessments; 59 in the intervention group and
57 in the control group.
Table 2 shows the numbers of women in both
groups with a diagnosis of secondary lymphoedema.
The incidence of secondary lymphoedema in the con-
trol group (14 cases, 25%) was significantly higher than
in the intervention group (four cases, 7%; P=0.010).
Risk factors for secondary lymphoedema1822-24 were
similar between the groups, therefore adjustment for
these was not necessary (table 1). Body mass index
was higher in the intervention group, therefore the
odds ratio for treatment was adjusted by body mass
index (table 2). The crude effect showed no difference.
Table 3 compares the continuous variables for the
outcome (parametric tests) between the groups. By the
12 month follow-up visit the volume ratio between
arms had increased in both groups: in the control
group the volume of the affected arm was on average
5.1% greater than that of the unaffected arm, whereas
in the intervention group the affected armwas on aver-
age only 1.6% greater than the unaffected arm. The
difference between groups was significant (P=0.0065).
Themaximum difference between two adjacent points
was on average also larger in the control group than in
the intervention group (1.15 cm v 0.68 cm, P=0.0207).
Figures 2 and 3 show the distributions of these vari-
ables in the groups. The distributions in the control
group are more skewed to the right.
The rate of survival was better in the intervention
group than in the control group. Secondary lympho-
edema developed four times more rapidly in the con-
trol group (intervention group/control group, hazard
ratio 0.26, 95% confidence interval 0.09 to 0.79;
P=0.010). The shape of the failure curves (1 minus sur-
vival) suggests that the protective effect of early physio-
therapy remained for a long time, whereas the
proportion of patients with a diagnosis of secondary
lymphoedema in the control group increased progres-
sively (fig 4).
DISCUSSION
Early physiotherapy with an educational strategy after
surgery for breast cancer that involved dissection of
axillary lymph nodes was associated with a lower risk
of secondary lymphoedema than the educational strat-
egy only (control group) after 12 months of follow-up:
25% in the control group compared with 7% in the
intervention group. Secondary lymphoedema devel-
oped from six to 12 months postoperatively, which
agrees with previous studies.29 30 This could be due to
the sum of various risk factors associated with second-
ary lymphoedema: axillary lymph node dissection, the
number of lymph nodes removed (between 10 and 20
nodes were removed in 17 of the 18 women with sec-
ondary lymphoedema), overweight (12 of the 18
women had a body mass index >25), and postopera-
tive complications (all 18 women had postoperative
complications) along with the effect of radiotherapy
(completed in the fourth postoperative month) as well
as the gradual weight gain (11 of 12 women with sec-
ondary lymphoedema who were overweight at base-
line progressively increased in weight from six
months after surgery).18 20 21 23 24 Further investigation
of these risk factors is needed.
Table 2 | Comparison of secondary lymphoedema in groups
Group
Early physiotherapy
group (n=59)
Control group
(n=57)
Odds ratio
(95% CI) P value
No (%) with lymphoedema 4 (7) 14 (25)
Early physiotherapy v control* 0.28 (0.10 to 0.79)† — 0.22 (0.07 to 0.73) 0.010
Early physiotherapy v control‡ — — 0.22 (0.07 to 0.72) 0.013
*Crude effect.
†Risk ratio (95% confidence interval).
‡Adjusted for body mass index.
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Fig 2 | Increase in volume ratios between arms. Vertical lines
correspond to cut-off values for diagnoses of lymphoedema in
other studies (>5% and >10% increase)
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Secondary lymphoedema is thought to be caused by
damage to the axillary lymphatic system, impairing
lymph drainage from the arm, although there is strong
evidence that total blood flow in the arm and vascular
bed size are increased in secondary lymphoedema.1
Recently, a study to develop an animal model of post-
surgical lymphoedema reported that after nodal exci-
sions the limbs became progressively more
oedematous up to three days after node dissection
and that the swelling decreased but had not resolved
16 weeks after surgery.58 Taking this into account and
since the basic rule is that all oedemas result from an
imbalance between filtration and resorption (tissue
drainage), the implementation of a measure to restore
this balance during the period of higher filtration
should prevent or delay the onset of secondary
lymphoedema. Our study included manual lymph
drainage, which is a special method involving gentle
massage to improve the lymph circulation, especially
subcutaneous circulation, to stimulate the initial lym-
phatics, and to stretch the lymph vessels, consequently
improving the removal of interstitial fluid. Manual
lymph drainage encourages and improves resorption
without increasing filtration.3459 It has been shown to
be effective in the treatment of lymphoedema because
it improves the removal of fluid from interstitial
space.32 34 59 60 We therefore think that the implementa-
tion of manual lymph drainage after surgery for breast
cancer in the early physiotherapy group could have
contributed to the better results in that group. This,
together with early physiotherapy for other effects of
breast cancer surgery, and related to the onset of sec-
ondary lymphoedema,18 20 21 23 24 could explain the
effectiveness of early physiotherapy in the prevention
of secondary lymphoedema in women who have had
surgery for breast cancer with axillary lymph node dis-
section—at least during the first year after surgery.
We also found that 12 of the 18 women who devel-
oped secondary lymphoedema had axillary web syn-
drome during the second and third week after surgery.
The axillary web syndrome is a known but poorly stu-
died complication of surgery.54 61 62 No study has
shown any link between the axillary web syndrome
and the onset of secondary lymphoedema. We and
others32 50 suggest that the axillary web syndrome
may be a sign of injury to the lymphatic system and it
could produce a lymphatic overload as a result of fail-
ure of the lymphatic system. This overload, together
with other factors, could be responsible for the onset
of secondary lymphoedema. When axillary web syn-
drome was diagnosed in the postoperative period in
the intervention group, specific manual lymph drai-
nage strokes were applied, together with progressive
active and action assisted shoulder and arm exercises.
Manual lymph drainage acted on the pain and inflex-
ibility inherent to the vascular inflammation of the
lymphatic vessel; also, if the axillary web syndrome
did produce a lymphatic overload, and therefore a
possible subclinical oedema, the action of the manual
lymphdrainage could helpwith reabsorption.32 34 59 60 63
Further research on a possible relation between the
axillary web syndrome and the development of sec-
ondary lymphoedema in women after breast cancer
surgery is needed.
Comparison with other studies
Secondary lymphoedema is a common complication
of breast cancer surgery.2-5 As far as we are aware, only
one study has examined the effect of exercise and spe-
cific recommendations about self care to minimise the
onset of secondary lymphoedema.29 30 In addition, sev-
eral studies on the effectiveness of early rehabilitation
after breast surgery reported data on lymphoedema as
secondary end points.64-68 Box and colleagues evalu-
ated an intervention to minimise postoperative
lymphoedema in 65 women and stated that a physio-
therapy management care plan, including exercise
strategies thatwere not described in the paper, andpro-
gressive educational strategies may reduce the occur-
rence of secondary lymphoedema two years after
surgery.30 Our results for onset of secondary lympho-
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Fig 3 | Maximum increase in arm circumference (affected arm
−unaffected arm) that could be observed at least at two
adjacent points. Vertical line corresponds to binary criteria
used here to diagnose lymphoedema—that is, a 2 cm or
greater increase in arm circumference observed at least at two
adjacent points in affected arm compared with unaffected arm
Table 3 | Continuous analysis of circumferential and volume measurements. Values are means
(standard deviations) unless stated otherwise
Measures Follow-up
Early physiotherapy
group (n=59)
Control group
(n=57) P value*
Change in volume ratio Baseline to 12 months 1.6 (5.6) 5.1 (7.6) 0.0065
Maximum circumference† 12 months 0.68 (0.91) 1.15 (1.21) 0.0207
*Student’s t test.
†Maximum difference measured between two adjacent points.
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edema one year after surgery are better than their
results. Exercise is used in the management of second-
ary lymphoedema of the arm to promote the recruit-
ment of collateral lymphatics pathways.69 This might
explain the difference in results between the studies.
The intervention programme in the study by Box and
colleagues did not include the diagnosis and treatment
of postoperative vascular complications (such as ser-
oma and axillary web syndrome), which could be
related to the onset of lymphoedema and could benefit
from a proper manual physiotherapy.50-53
Many studies have assessed the effectiveness of reha-
bilitation in patients after breast cancer surgery.64-68 All
of thempresent limitations in the sample size and assert
that physiotherapy is beneficial for shoulder mobility
and functional capacitywithout causing adverse effects
in the postoperative period, but not in preventing sec-
ondary lymphoedema. All the studies focused on the
recovery or maintenance of the mobility of the
shoulder so that the interventionwas basedonmobility
and stretching exercises of the shoulder.64-68 Only one
study included massage (not manual lymph drainage)
in one of the intervention groups. This group showed
better results, but the onset of lymphoedema was not
prevented.65 The development of restricted shoulder
mobility is one of themost important factors impairing
functional activities of patients after breast surgery.70 A
delayed onset physiotherapy programme as required
has been suggested to improve shoulder mobility and
daily activities of living.71 None of these studies could
correlate the exercise programmewith the incidence of
lymphoedema.64-68 Our results in relation to the study
by Box and colleagues30 could result from the early
diagnosis and treatment of postoperative vascular
complications.
Strengths and limitations of the study
We believe that our study shows evidence of the posi-
tive effect of early physiotherapy in the prevention of
secondary lymphoedema, but the study is limited by
the duration of follow-up (one year after surgery) and
recruitment in just one hospital. Although we have no
reason to suspect systematic differences in care pro-
vided by this hospital and other regional hospitals or
hospitals in other developed countries, this may limit
the external validity of the results. Furthermore, that
the physiotherapy was provided by trained physio-
therapists may limit the generalisability of this inter-
vention to other settings.
Another limitation is that we chose a particular cri-
terion for diagnosing lymphoedema. We followed the
criterion specified in our protocol but other criteria
could have been used. For example, if the criterion of
a greater than 10% increase in the volume ratio
between arms (affected v unaffected) had been chosen,
the patients with a diagnosis of secondary lympho-
edema would be those appearing to the right of the
vertical line furthest to the right in figure 2. Using this
criterion the early physiotherapy group would have
three cases (5%) and the control group 13 (23%), with
a risk ratio of 0.22 (95% confidence interval 0.06 to
0.74); results similar to those in table 2.
A further limitation is thepossibility ofmeasurement
errors. We have no reason to believe, however, that
this will have a differential effect on both intervention
and control groups. The physiotherapist who took the
measurements was blinded to the patient’s treatment
allocation. Both groups were reasonably balanced for
baseline characteristics. The use of ratios between arms
also reduces errors that could be correlated with some
patient characteristics, such as body mass index. In
general, we believe that measurement error might
have the effect of slightly increasing the variance in
the measurement, but not in a biased way. At the
most, this would reduce statistical power of the com-
parisons to identify differences but would not invali-
date the ones observed.
Conclusion
Early physiotherapy could help to prevent and reduce
secondary lymphoedema in patients after breast can-
cer surgery involving dissection of axillary lymph
nodes, at least for one year after surgery. This result
emphasises the role of physiotherapy in the awareness,
prevention, early diagnosis, and treatment of second-
ary lymphoedema.
Secondary lymphoedema is a chronic condition,
which has negative effects on the quality of life of
patients. The increase in risk factors associated with
secondary lymphoedema, such as ageing populations
and the growing prevalence of obesity,18 23 24 alongwith
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Fig 4 | Failure time for development of secondary
lymphoedema by group
WHAT IS ALREADY KNOWN ON THIS TOPIC
Secondary lymphoedema is the most important chronic complication after breast cancer
surgery with dissection of axillary lymph nodes
Early postsurgical rehabilitation improves shoulder mobility and functional capacity without
causing adverse effects but does not prevent secondary lymphoedema
WHAT THIS STUDY ADDS
Early physiotherapy with an educational strategy compared with the educational strategy
alone was associated with a lower risk of secondary lymphoedema 12 months after surgery
for breast cancer with axillary node dissection
The axillary web syndrome was an important complication in the immediate postoperative
period
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the gradual improvement in rates of survival from
cancer,26 suggest that secondary lymphoedema will
remain a challenge. Further studies are needed to clar-
ifywhether early physiotherapy after breast cancer sur-
gery can remain effective in preventing secondary
lymphoedema in the longer term.
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